Skip to main content
. 2025 Aug 19;25(1):296. doi: 10.1007/s10238-025-01770-4

Table 1.

Characteristic of patient population (N = 9110)

Characteristic N (%)
Median age(range) 55 (10–95)
Gender
Male 6416 (70.4)
Female 2694 (29.6)
Location
Left 4406 (48.4)
Right 4686 (51.4)
Bilateral 18 (0.2)
Site
One site 8923 (97.9)
Two sites 157 (1.7)
Multiple sites 30 (0.4)
Surgical approach
Radical nephrectomy 4359 (47.8)
Partial nephrectomy 4751 (52.2)
Pathological classification
ccRCC 7979 (87.6)
chRCC 468 (5.1)
pRCC 334 (3.7)
TFE-3 related RCC 79 (0.87)
Unclassified RCC 65 (0.7)
ccpRCC 21 (0.02)
Others 164 (1.8)
pT stage
pT1 7250 (79.6)
pT2 355 (3.9)
pT3 1366 (15.0)
pT4 30 (0.3)
pTx 109 (1.2)
cT stage
cT1a 4851 (53.3)
cT1b 2407 (26.4)
cT2 597 (6.6)
cT3a 977 (10.6)
cT3b 217 (2.4)
cT3c 25 (0.3)
cT4 36 (0.4)
G grade
G1 4330 (47.5)
G2 3468 (38.1)
G3 706 (7.7)
G4 60 (0.7)
Gx 546 (6.0)
Sarcomatoid differentiation
Yes 202 (2.2)
No 8908 (97.8)
Necrosis
Yes 1175 (12.9)
No 7935 (87.1)
Venous tumor thrombus
Yes 182 (2.0)
No 8928 (98.0)

* ccRCC, clear cell renal cell carcinoma; chRCC, chromophobe renal cell carcinoma; pRCC, papillary renal cell carcinoma; ccpRCC, clear cell papillary renal cell carcinoma; pT stage, pathological T stage; cT stage, clinical T stage